Advertisement
Screener

Renalytix plc (RNLXY) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

Renalytix plc Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

Renalytix plc (RNLXY) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 517.50 thousand shares for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-19.

Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2024-11-19

  • Renalytix plc share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-09-30 was 517.50K shares, a 80.64% decline year-over-year.
  • Renalytix plc share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-06-30 was 74.75K shares, a 367.19% increase year-over-year.
  • Renalytix plc share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-03-31 was 892.25K shares.
  • Renalytix plc share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-12-31 was 0.00 shares, a 100.00% decline year-over-year.
  • Renalytix plc share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 3.64M shares, a 537.20% increase from fiscal 2023.
  • Renalytix plc share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 571.30K shares.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month
2024-09-30517.50K shares
10-Q · filed 2024-11-19
592.25K shares
derived: sum of 2 quarters · filed 2024-11-19
1.48M shares
derived: sum of 3 quarters · filed 2024-11-19
1.48M shares
derived: sum of 4 quarters · filed 2024-11-19
2024-06-3074.75K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30
967.00K shares
derived: sum of 2 quarters · filed 2024-09-30
967.00K shares
derived: sum of 3 quarters · filed 2024-09-30
3.64M shares
10-K · filed 2024-09-30
2024-03-31892.25K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-15
892.25K shares
derived: sum of 2 quarters · filed 2024-05-15
3.57M shares
10-Q · filed 2024-05-15
3.58M shares
derived: sum of 4 quarters · filed 2024-05-15
2023-12-310.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-14
2.67M shares
10-Q · filed 2024-02-14
2.69M shares
derived: sum of 3 quarters · filed 2024-02-14
2.69M shares
derived: sum of 4 quarters · filed 2024-02-14
2023-09-302.67M shares
10-Q · filed 2023-11-14
2.69M shares
derived: sum of 2 quarters · filed 2023-11-14
2.69M shares
derived: sum of 3 quarters · filed 2023-11-14
3.16M shares
derived: sum of 4 quarters · filed 2023-11-14
2023-06-3016.00K shares
derived: 10-K 12 month − 6-K 9 month · filed 2023-09-28
16.00K shares
derived: sum of 2 quarters · filed 2023-09-28
491.30K shares
derived: sum of 3 quarters · filed 2023-09-28
571.30K shares
10-K · filed 2023-09-28
2023-03-310.00 shares
derived: 6-K 9 month − 6-K 6 month · filed 2023-06-09
475.30K shares
derived: sum of 2 quarters · filed 2023-06-09
555.30K shares
6-K · filed 2023-06-09
595.30K shares
derived: sum of 4 quarters · filed 2023-06-09
2022-12-31475.30K shares
derived: 6-K 6 month − 6-K 3 month · filed 2023-03-30
555.30K shares
6-K · filed 2023-03-30
595.30K shares
derived: sum of 3 quarters · filed 2023-03-30
784.30K shares
derived: sum of 4 quarters · filed 2023-03-30
2022-09-3080.00K shares
6-K · filed 2022-11-30
120.00K shares
derived: sum of 2 quarters · filed 2022-11-30
309.00K shares
derived: sum of 3 quarters · filed 2022-11-30
2022-06-3040.00K shares
derived: 20-F 12 month − 6-K 9 month · filed 2022-10-31
229.00K shares
derived: sum of 2 quarters · filed 2022-10-31
555.00K shares
20-F · filed 2022-10-31
2022-03-31189.00K shares
derived: 6-K 9 month − 6-K/A 6 month · filed 2022-06-30
515.00K shares
6-K · filed 2022-06-30
2021-12-31326.00K shares
6-K/A · filed 2022-04-29
2021-06-301.39M shares
20-F/A · filed 2022-08-01
2020-06-30833.16K shares
20-F/A · filed 2020-11-10
2019-06-302.20M shares
20-F/A · filed 2020-11-10